Latest news
Loading news…
Actelion Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of low molecular weight drugs for
Actelion Pharmaceuticals was acquired by Johnson & Johnson in 2017 for $30B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
4
Monthly Visits
Available in Pro Contacts
67
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Allschwil, Basel-Landschaft, Switzerland
Acquisitions by Actelion Pharmaceuticals
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Actelion Pharmaceuticals
Member of the Board
Co-Founder
Consultant
Co-Founder
Executive Vice-President & Head of Global Clinical Development
Member of the Board of Directors
Member of Board of Directors
67
professional contacts at Actelion Pharmaceuticals
Contact execs at Actelion Pharmaceuticals →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Actelion Pharmaceuticals
Loading news…
FAQs about Actelion Pharmaceuticals
People who checked this page also checked these
Sectors Actelion Pharmaceuticals invests & acquires in
Browse the full Acquirezy directory.